FCM

Farallon Capital Management Portfolio holdings

AUM $21.3B
This Quarter Return
+10.36%
1 Year Return
+23.12%
3 Year Return
+87.19%
5 Year Return
+183.94%
10 Year Return
+836.54%
AUM
$21.3B
AUM Growth
+$21.3B
Cap. Flow
+$1.95B
Cap. Flow %
9.16%
Top 10 Hldgs %
45.78%
Holding
160
New
16
Increased
36
Reduced
30
Closed
18

Sector Composition

1 Healthcare 34.23%
2 Technology 14.54%
3 Financials 10.03%
4 Communication Services 6.05%
5 Industrials 5.73%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
GKOS icon
101
Glaukos
GKOS
$5.5B
$269K ﹤0.01% 2,600
ONC
102
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$266K ﹤0.01% 1,100
ACLX icon
103
Arcellx
ACLX
$3.85B
$263K ﹤0.01% 4,000
SBRA icon
104
Sabra Healthcare REIT
SBRA
$4.58B
$258K ﹤0.01% 14,000
GRFS icon
105
Grifois
GRFS
$6.78B
$253K ﹤0.01% 28,000
ARWR icon
106
Arrowhead Research
ARWR
$3.05B
$250K ﹤0.01% 15,800
SRRK icon
107
Scholar Rock
SRRK
$3.14B
$248K ﹤0.01% 7,000
ASND icon
108
Ascendis Pharma
ASND
$11.8B
$242K ﹤0.01% 1,400
SWTX
109
DELISTED
SpringWorks Therapeutics
SWTX
$235K ﹤0.01% 5,000 -113,000 -96% -$5.31M
ANNAW
110
AleAnna, Inc. Warrant
ANNAW
$8.72M
$233K ﹤0.01% 990,000
AKRO icon
111
Akero Therapeutics
AKRO
$3.74B
$213K ﹤0.01% +4,000 New +$213K
CGON icon
112
CG Oncology
CGON
$2.04B
$208K ﹤0.01% +8,000 New +$208K
BRKR icon
113
Bruker
BRKR
$5.16B
$206K ﹤0.01% 5,000
QURE icon
114
uniQure
QURE
$896M
$195K ﹤0.01% 14,000
IMVT icon
115
Immunovant
IMVT
$2.56B
$192K ﹤0.01% 12,000
HR icon
116
Healthcare Realty
HR
$6.11B
$190K ﹤0.01% 12,000
TVTX icon
117
Travere Therapeutics
TVTX
$1.56B
$178K ﹤0.01% +12,000 New +$178K
PACB icon
118
Pacific Biosciences
PACB
$393M
$167K ﹤0.01% 135,000
EVH icon
119
Evolent Health
EVH
$1.12B
$158K ﹤0.01% 14,000
SLDPW icon
120
Solid Power, Inc. Warrant
SLDPW
$94.9M
$152K ﹤0.01% 405,316
COGT icon
121
Cogent Biosciences
COGT
$1.69B
$122K ﹤0.01% 17,000
ALT icon
122
Altimmune
ALT
$338M
$107K ﹤0.01% 27,600
NVAX icon
123
Novavax
NVAX
$1.21B
$101K ﹤0.01% 16,000
DYN icon
124
Dyne Therapeutics
DYN
$1.92B
$95.2K ﹤0.01% 10,000
SNDX icon
125
Syndax Pharmaceuticals
SNDX
$1.41B
$93.7K ﹤0.01% 10,000